Congenital Heart Defect Devices Market Anticipated to Record Steady Gains, Advancing to $4.44 Billion by 2030
Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What upper market value could the Congenital Heart Defect Devices Market reach by 2030 starting from 2026 levels?
The congenital heart defect devices market size has demonstrated strong growth in recent years. It is forecast to expand from $3.11 billion in 2025 to $3.34 billion in 2026, with a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historic period stems from the rising incidence of congenital heart defects, advancements in pediatric cardiac surgery, increasing survival rates of congenital heart patients, the expansion of specialized cardiac care centers, and growing awareness of early congenital defect diagnosis.
The congenital heart defect devices market is anticipated to experience substantial growth over the coming years, projected to reach $4.45 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.4%. This expansion during the forecast period is driven by several factors, including an increased emphasis on early diagnosis and intervention, a growing need for less invasive pediatric cardiac treatments, broader availability of advanced cardiac care in developing regions, a rising number of adults living with congenital heart disease, and ongoing advancements in implantable cardiac devices. Key developments expected during this period involve the increasing adoption of minimally invasive congenital heart procedures, greater utilization of transcatheter and implantable cardiac devices, an intensified focus on cardiac interventions for infants and children, the wider application of device-based therapies for intricate heart defects, and a heightened demand for devices supporting long-term cardiac monitoring.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18543&type=smp
Which Drivers Are Influencing Long-Term Growth In The Congenital Heart Defect Devices Market?
The escalating volume of minimally invasive procedures is projected to drive the expansion of the congenital heart defect device market. These procedures involve surgical interventions performed with minimal incisions or through existing body openings, frequently utilizing specialized instruments and techniques to reduce trauma and enhance recovery. The increase in minimally invasive procedures is attributed to advancements in technology, patients’ preference for less intrusive treatments, enhanced surgical methods, and the benefits of reduced recovery periods and complications. Congenital heart defect devices are employed in minimally invasive procedures by facilitating the identification, treatment, and management of cardiac abnormalities through approaches that involve smaller incisions or catheter-based techniques. For example, in June 2024, data from the American Society of Plastic Surgeons, a US-based organization, showed that in 2023, plastic surgeries rose by 5%, while minimally invasive procedures increased by 7% compared to the preceding year. Thus, the rising prevalence of minimally invasive procedures is propelling the congenital heart defect devices market.
How Is The Congenital Heart Defect Devices Market Divided Into Segments?
The congenital heart defect devices market covered in this report is segmented –
1) By Device Type: Catheters, Pacemakers, Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers, Implantable Cardioverter Defibrillators, Biventricular Devices, Implanted Cardiac Loop Recorders, Other Device Types
2) By Defect Type: Atrial Septal Defect, Ventricular Septal Defect, Atrioventricular Septal Defect, Tricuspid Atresia, Truncus Arteriosus, Other Defect Types
3) By End user: Hospitals, Specialty Clinics, Academic And Research Institute, Other End Users
Subsegments:
1) By Catheters: Balloon Catheters, Diagnostic Catheters, Guiding Catheters
2) By Pacemakers: Single-Chamber Pacemakers, Dual-Chamber Pacemakers, Biventricular Pacemakers, Leadless Pacemakers
3) By Implantable Cardioverter Defibrillators: Single-Chamber Icds, Dual-Chamber Icds, Subcutaneous Icds
4) By Biventricular Devices: Crt-P (Cardiac Resynchronization Therapy Pacemakers), Crt-D (Cardiac Resynchronization Therapy Defibrillators)
5) By Implanted Cardiac Loop Recorders: Traditional Implantable Loop Recorders, Subcutaneous Implantable Loop Recorders
6) By Other Device Types: Transcatheter Heart Valves, Ventricular Assist Devices (VADS)
What Long-Term Trends Are Expected To Shape The Future Of The Congenital Heart Defect Devices Market?
Key companies operating within the congenital heart defect devices market are adopting a strategic partnership approach to create innovative devices. These alliances offer support to businesses in the congenital heart defect devices sector by combining resources and specialized knowledge, intensifying research and development efforts, broadening market reach, and accelerating commercialization. This collaborative approach ultimately fosters innovation and stimulates growth across the industry. As an illustration, in May 2024, SMT (Sahajanand Medical Technologies Pvt Ltd), an India-based manufacturing enterprise, formed a partnership with HeartX, an India-based MedTech firm, to improve patient care within the cardiovascular sector. Through this collaboration, Sahajanand Medical Technologies (SMT) strengthens its position in the congenital heart defect (CHD) space by integrating HeartX’s innovative solutions, such as the JOVE VB Stent. This strategic alliance allows SMT to provide advanced CHD devices that enhance treatment effectiveness, simplify medical procedures, and improve patient outcomes.
Which Major Firms Are Strengthening Their Position In The Congenital Heart Defect Devices Market?
Major companies operating in the congenital heart defect devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Congenital Heart Defect Devices Market?
North America was the largest region in the congenital heart defect devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the congenital heart defect devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Congenital Heart Defect Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18543&type=smp
Browse Through More Reports Similar to the Global Congenital Heart Defect Devices Market 2026, By The Business Research Company
Computed Tomography Ct Scanners Devices And Equipment Global Market Report 2026
Computed Tomography Ct Scanner Global Market Report 2026
Positron Emission Tomography Pet Scanners Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
